IART
IART
US4579852082
Integra LifeSciences Holdings C
Loading chart...

Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Latest News

Related stocks

AORT
AORT • United States
Artivion, Inc.
21.26 USD
1.04B USD 1Y -48.3%
LMRI
LMRI • United States
Lumexa Imaging Holdings, Inc.
10.54 USD
1.01B USD
BBNX
BBNX • United States
Beta Bionics, Inc.
17.63 USD
951.07M USD 1Y -21.2%
CBLL
CBLL • United States
CeriBell, Inc.
23.63 USD
906.87M USD 1Y +89.1%
PRCT
PRCT • United States
PROCEPT BioRobotics Corporation
18.4 USD
1.05B USD 1Y -48.5%
ENOV
ENOV • United States
Enovis Corporation
17.69 USD
1.02B USD 1Y -45.2%
CTKB
CTKB • United States
Cytek Biosciences, Inc.
5.43 USD
705.81M USD 1Y +37.4%
ALMR
ALMR • United States
Alamar Biosciences, Inc.
25.27 USD
1.75B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
49.3% p.a.
Max Drawdown (5Y)
-87.8%
Sharpe Ratio (5Y)
-0.61
Beta Factor
1.21
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (57.7%) is noticeably higher than the 5Y average (49.3%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (49.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -88.4% in the extended horizon.
ende